bromocriptine has been researched along with Neoplasm Metastasis in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (71.43) | 18.7374 |
1990's | 4 (28.57) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Foa, J; Grisoli, F; Lavail, G; Salamon, G; Vincentelli, F | 1 |
Ausfeld, R; Del Pozo, E; Huber, P | 1 |
Altwein, JE; Faul, P | 1 |
Di Carlo, F; Dogliotti, L; Mussa, A | 2 |
Modigliani, E | 1 |
Schulz, KD | 1 |
Giraldi, T; Perissin, L; Rapozzi, V; Zorzet, S | 1 |
Cornelisse, CJ; Keijzer, R; van de Velde, CJ; van Dierendonck, JH; Wijsman, JH | 1 |
Fujimoto, NA; Ito, A; Ito, N; Nakamura, A; Ogawa, K; Shirai, T; Wada, S | 1 |
Brame, K; Camplejohn, RS; Chaudary, MA; Fentiman, IS; Millis, RR; Wang, DY | 1 |
Abel, U; Edler, L; Fritze, D; Kaufmann, M; Massner, B; Queisser, W; Schmid, H; Schmidt, R; Westerhausen, M | 1 |
Holtkamp, W; Nagel, GA | 1 |
Horvath, E; Kovacs, KT; Laws, ER; Randall, RV; Scheithauer, BW; Whitaker, MD | 1 |
1 review(s) available for bromocriptine and Neoplasm Metastasis
Article | Year |
---|---|
[Advanced prostatic cancer: therapeutic modalities].
Topics: Acid Phosphatase; Antineoplastic Agents; Bromocriptine; Castration; Combined Modality Therapy; Cyproterone; Estramustine; Estrogens; Fluorouracil; Humans; Lisuride; Male; Neoplasm Metastasis; Prostatic Neoplasms; Random Allocation | 1984 |
5 trial(s) available for bromocriptine and Neoplasm Metastasis
Article | Year |
---|---|
[Value of palliative treatment of metastasizing prostatic cancer with the prolactin inhibitor parlodel].
Topics: Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Humans; Male; Neoplasm Metastasis; Palliative Care; Prolactin; Prostatic Neoplasms; Random Allocation | 1982 |
[Bromocriptine in metastasizing breast cancer].
Topics: Breast Neoplasms; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Neoplasm Metastasis | 1979 |
Perioperative bromocriptine adjuvant treatment for operable breast cancer.
Topics: Breast Neoplasms; Bromocriptine; Clinical Trials as Topic; Combined Modality Therapy; DNA, Neoplasm; Double-Blind Method; Female; Flow Cytometry; Humans; Intraoperative Period; Mastectomy; Middle Aged; Neoplasm Metastasis; Pilot Projects; Prolactin; Random Allocation | 1988 |
Prospective randomized trial concerning hyper- and normoprolactinemia and the use of bromoergocryptine in patients with metastatic breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bromocriptine; Cyclophosphamide; Dactinomycin; Female; Fluorouracil; Humans; Hyperprolactinemia; Medroxyprogesterone; Medroxyprogesterone Acetate; Methotrexate; Middle Aged; Neoplasm Metastasis; Prognosis; Prolactin; Vincristine | 1986 |
[Bromocriptine in chemotherapy-resistant, metastatic breast cancer. Results of the GO-MC-BROMO 2/82 AIO Study].
Topics: Breast Neoplasms; Bromocriptine; Clinical Trials as Topic; Drug Resistance; Female; Humans; Neoplasm Metastasis; Prognosis; Prolactin; Receptors, Estrogen; Receptors, Progesterone | 1988 |
8 other study(ies) available for bromocriptine and Neoplasm Metastasis
Article | Year |
---|---|
Effect of bromocriptine on brain metastasis in breast cancer.
Topics: Brain Neoplasms; Breast Neoplasms; Bromocriptine; Carcinoma, Intraductal, Noninfiltrating; Female; Humans; Middle Aged; Neoplasm Metastasis | 1981 |
[Overall evaluation of the results of treatment of metastatic carcinomas of the breast with high doses of MAP combined with bromocryptin].
Topics: Adult; Aged; Breast Neoplasms; Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis | 1980 |
Medullary thyroid carcinoma.
Topics: Adrenal Gland Neoplasms; Antineoplastic Agents; Bromocriptine; Carcinoma, Medullary; Humans; Iodine Radioisotopes; Levodopa; Lymph Node Excision; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Octreotide; Pheochromocytoma; Recurrence; Survival Rate; Thyroid Neoplasms; Thyroidectomy | 1994 |
[Preliminary results of treatment of hormone-dependent metastatic carcinoma of the breast with the bromocriptin-medroxyprogesterone acetate combination].
Topics: Adult; Aged; Breast Neoplasms; Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Ergolines; Female; Humans; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis; Receptors, Estrogen | 1977 |
Metastasis and neuroendocrine system in stressed mice.
Topics: Animals; Bromocriptine; Carcinoma; Female; Guanethidine; Lung Neoplasms; Mice; Mitotane; Naltrexone; Neoplasm Metastasis; Neuroimmunomodulation; Reserpine; Stress, Psychological | 1992 |
A prolactin-dependent, metastasising rat mammary carcinoma as a model for endocrine-related tumour dormancy.
Topics: Animals; Bromocriptine; Cell Division; DNA, Neoplasm; Drug Implants; Estradiol; Female; Flow Cytometry; Mammary Neoplasms, Experimental; Neoplasm Metastasis; Neoplasm Regression, Spontaneous; Neoplasm Transplantation; Perphenazine; Ploidies; Prolactin; Rats; Rats, Inbred Strains | 1991 |
Promoting action of prolactin released from a grafted transplantable pituitary tumor (MtT/F84) on rat prostate carcinogenesis.
Topics: Aminobiphenyl Compounds; Animals; Bromocriptine; Carcinogens; Carcinoma; Cocarcinogenesis; Male; Neoplasm Metastasis; Neoplasm Transplantation; Organ Size; Pituitary Neoplasms; Precancerous Conditions; Prolactin; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred F344; Seminal Vesicles | 1990 |
Prolactin cell carcinoma of the pituitary. Clinicopathologic, immunohistochemical, and ultrastructural study of a case with cranial and extracranial metastases.
Topics: Biological Assay; Brain Neoplasms; Bromocriptine; Combined Modality Therapy; Ergolines; Female; Histocytochemistry; Hormones; Humans; Microscopy, Electron; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Pergolide; Pituitary Neoplasms; Prolactin | 1985 |